A natriuretic peptides clearance receptor's agonist reduces pulmonary artery pressures and enhances cardiac performance in preclinical models: New hope for patients with pulmonary hypertension due to left ventricular heart failure

Emmanuel Eroume Egom; Tiam Feridooni; Rebabonye B. Pharithi; Barkat Khan; Haaris A. Shiwani; Vincent Maher; Yassine El Hiani; Kishore B.S. Pasumarthi; Hilaire A. Ribama

doi:10.1016/j.biopha.2017.07.027

A natriuretic peptides clearance receptor's agonist reduces pulmonary artery pressures and enhances cardiac performance in preclinical models: New hope for patients with pulmonary hypertension due to left ventricular heart failure

Emmanuel Eroume Egom, Tiam Feridooni, Rebabonye B. Pharithi, Barkat Khan, Haaris A. Shiwani, Vincent Maher, Yassine El Hiani, Kishore B.S. Pasumarthi, Hilaire A. Ribama

Research output: Contribution to journal › Article › peer-review

10 Citations (Scopus)

Original language	English
Pages (from-to)	1144-1150
Number of pages	7
Journal	Biomedicine and Pharmacotherapy
Volume	93
DOIs	https://doi.org/10.1016/j.biopha.2017.07.027
Publication status	Published - Sept 2017
Externally published	Yes

ASJC Scopus Subject Areas

Pharmacology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.biopha.2017.07.027

Fingerprint

Dive into the research topics of 'A natriuretic peptides clearance receptor's agonist reduces pulmonary artery pressures and enhances cardiac performance in preclinical models: New hope for patients with pulmonary hypertension due to left ventricular heart failure'. Together they form a unique fingerprint.

Cite this

Egom, E. E., Feridooni, T., Pharithi, R. B., Khan, B., Shiwani, H. A., Maher, V., El Hiani, Y., Pasumarthi, K. B. S., & Ribama, H. A. (2017). A natriuretic peptides clearance receptor's agonist reduces pulmonary artery pressures and enhances cardiac performance in preclinical models: New hope for patients with pulmonary hypertension due to left ventricular heart failure. Biomedicine and Pharmacotherapy, 93, 1144-1150. https://doi.org/10.1016/j.biopha.2017.07.027

A natriuretic peptides clearance receptor's agonist reduces pulmonary artery pressures and enhances cardiac performance in preclinical models: New hope for patients with pulmonary hypertension due to left ventricular heart failure. / Egom, Emmanuel Eroume; Feridooni, Tiam; Pharithi, Rebabonye B. et al.
In: Biomedicine and Pharmacotherapy, Vol. 93, 09.2017, p. 1144-1150.

Research output: Contribution to journal › Article › peer-review

Egom, EE, Feridooni, T, Pharithi, RB, Khan, B, Shiwani, HA, Maher, V, El Hiani, Y, Pasumarthi, KBS & Ribama, HA 2017, 'A natriuretic peptides clearance receptor's agonist reduces pulmonary artery pressures and enhances cardiac performance in preclinical models: New hope for patients with pulmonary hypertension due to left ventricular heart failure', Biomedicine and Pharmacotherapy, vol. 93, pp. 1144-1150. https://doi.org/10.1016/j.biopha.2017.07.027

Egom EE, Feridooni T, Pharithi RB, Khan B, Shiwani HA, Maher V et al. A natriuretic peptides clearance receptor's agonist reduces pulmonary artery pressures and enhances cardiac performance in preclinical models: New hope for patients with pulmonary hypertension due to left ventricular heart failure. Biomedicine and Pharmacotherapy. 2017 Sept;93:1144-1150. doi: 10.1016/j.biopha.2017.07.027

Egom, Emmanuel Eroume ; Feridooni, Tiam ; Pharithi, Rebabonye B. et al. / A natriuretic peptides clearance receptor's agonist reduces pulmonary artery pressures and enhances cardiac performance in preclinical models : New hope for patients with pulmonary hypertension due to left ventricular heart failure. In: Biomedicine and Pharmacotherapy. 2017 ; Vol. 93. pp. 1144-1150.

@article{2eed6916d0d248e38d71dc28d6081d31,

title = "A natriuretic peptides clearance receptor's agonist reduces pulmonary artery pressures and enhances cardiac performance in preclinical models: New hope for patients with pulmonary hypertension due to left ventricular heart failure",

author = "Egom, {Emmanuel Eroume} and Tiam Feridooni and Pharithi, {Rebabonye B.} and Barkat Khan and Shiwani, {Haaris A.} and Vincent Maher and {El Hiani}, Yassine and Pasumarthi, {Kishore B.S.} and Ribama, {Hilaire A.}",

note = "Funding Information: This study was sponsored by ECTRS Lt (Dartmouth, Canada) and Bonsai Horizons Lt (Dublin, Ireland) (EEE), Grant-in-aid from the Heart and Stroke Foundation of Canada (KP); NSHRF studentship (TF). Publisher Copyright: {\textcopyright} 2017 Elsevier Masson SAS",

year = "2017",

month = sep,

doi = "10.1016/j.biopha.2017.07.027",

language = "English",

volume = "93",

pages = "1144--1150",

journal = "Biomedicine and Pharmacotherapy",

issn = "0753-3322",

publisher = "Elsevier Masson",

}

TY - JOUR

T1 - A natriuretic peptides clearance receptor's agonist reduces pulmonary artery pressures and enhances cardiac performance in preclinical models

T2 - New hope for patients with pulmonary hypertension due to left ventricular heart failure

AU - Egom, Emmanuel Eroume

AU - Feridooni, Tiam

AU - Pharithi, Rebabonye B.

AU - Khan, Barkat

AU - Shiwani, Haaris A.

AU - Maher, Vincent

AU - El Hiani, Yassine

AU - Pasumarthi, Kishore B.S.

AU - Ribama, Hilaire A.

N1 - Funding Information: This study was sponsored by ECTRS Lt (Dartmouth, Canada) and Bonsai Horizons Lt (Dublin, Ireland) (EEE), Grant-in-aid from the Heart and Stroke Foundation of Canada (KP); NSHRF studentship (TF). Publisher Copyright: © 2017 Elsevier Masson SAS

PY - 2017/9

Y1 - 2017/9

UR - http://www.scopus.com/inward/record.url?scp=85024867681&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85024867681&partnerID=8YFLogxK

U2 - 10.1016/j.biopha.2017.07.027

DO - 10.1016/j.biopha.2017.07.027

M3 - Article

C2 - 28738523

AN - SCOPUS:85024867681

SN - 0753-3322

VL - 93

SP - 1144

EP - 1150

JO - Biomedicine and Pharmacotherapy

JF - Biomedicine and Pharmacotherapy

ER -

A natriuretic peptides clearance receptor's agonist reduces pulmonary artery pressures and enhances cardiac performance in preclinical models: New hope for patients with pulmonary hypertension due to left ventricular heart failure

ASJC Scopus Subject Areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this